Bio-Techne (TECH) Cash & Current Investments (2009 - 2026)

Bio-Techne's Cash & Current Investments history runs 18 years deep, the most recent figure standing at $209.8 million for Q1 2026.

• In Q1 2026, Cash & Current Investments rose 49.16% year-over-year to $209.8 million; the TTM figure through Mar 2026 stood at $209.8 million (up 49.16% YoY), while the FY2025 annual figure was $165.0 million, up 2.12% from the prior year.
• Cash & Current Investments was $209.8 million for Q1 2026 at Bio-Techne, up from $172.9 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $247.0 million in Q2 2022 to a low of $135.7 million in Q4 2023.
• Historically, Cash & Current Investments has averaged $179.4 million across 5 years, with a median of $172.9 million in 2025.
• The sharpest annual moves came in 2023 and 2026: Cash & Current Investments slumped 32.0% in 2023, then surged 49.16% in 2026.
• A 5-year view of Cash & Current Investments shows it stood at $196.8 million in 2022, then tumbled by 31.06% to $135.7 million in 2023, then jumped by 33.26% to $180.8 million in 2024, then retreated by 4.37% to $172.9 million in 2025, then gained by 21.37% to $209.8 million in 2026.
• The last three Cash & Current Investments figures came in at $209.8 million (Q1 2026), $172.9 million (Q4 2025), and $145.0 million (Q3 2025), per Business Quant data.